Corcept Therapeutics Inc

NASDAQ:CORT   1:00:00 PM EDT
72.27
+0.93 (+1.30%)
4:20:00 PM EDT: $72.27 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)7.66B
Current PE57.19
Forward PE 52.37
2yr Forward PE 27.17
See more stats
Estimates Current Quarter
Revenue$199.4 Million
Adjusted EPS$0.19
See more estimates
10-Day MA$72.31
50-Day MA$72.71
200-Day MA$60.81
See more pivots

Corcept Therapeutics Inc Stock, NASDAQ:CORT

101 Redwood Shores Parkway, Redwood City, California 94065
United States of America
Phone: +1.650.327.3270
Number of Employees: 500

Description

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company. It engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.